BlackBull_Markets

Dollar is going one way once the vaccine is out

TVC:DXY   U.S. Dollar Index
Dollar is going one way once the vaccine is out
The dollar has fallen from grace from the peak of the Coronavirus. The dollar index is down 10% from its yearly high in March, where traders and investors went to cash.

However, with two strong positive results from two vaccine makers Pfizer and Moderns with their 90% efficacy with their vaccine trial, solid news on when we will get a vaccine will solidify a bull trend and a rotation into value and cyclical stocks.

Institutions see weakness in the U.S Dollar
We can see that the US dollar has played well around the Fibonacci levels from April 2018 to its high early this year. It is currently sitting at the 78.6 % retracement, looking for targets at the 100% retracement and 168.1%., a full 20% drop.

Is there a bull case for the US Dollar?
As we saw at the start of the year, the rally was on extreme risk-off sentiment. Therefore, history suggests that we will only see a strong spike in the US dollar if there is risk-off sentiment, which is unlikely. We should also see some strength in the US dollar once the Federal reserve lifts quantitative easing.

Tse further stated, “There is plenty of reason to be optimistic” on the vaccine, and that the distribution “will catalyze the next leg lower in the structural USD downtrend we expect.”

Joe Biden a possible catalyst for the US Dollar
Mark McCormick, global head of FX strategy at TD Securities stated that “It’s likely, short term, the US dollar trades lower on the easing of geopolitical uncertainty”, citing that Biden is likely to back away from Donald Trump’s confrontational and “America First” trade policy.

What are your thoughts on the US Dollar?

Import the BlackBull Markets Economic Calendar:
blackbull.com/en/economic-calendar/?utm_source=tradingview

Free TradingView Essential with BlackBull Markets: www.blackbull.com/en/platforms/tradingview/?utm_source=tradingview
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.